Patents matching “The United States of America”

US 6749856

Mucosal cytotoxic T lymphocyte responses

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 15, 2004 · Expires Jun 10, 2024

US 6747055

Water-soluble drugs and methods for their production

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 8, 2004 · Expires Jun 3, 2024

US 6743797

Methods for treating cardiac arrhythmia

The United States of America · Granted Jun 1, 2004 · Expires May 27, 2024

US 6743626

Artificial salivary gland

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 1, 2004 · Expires May 27, 2024

US 6743577

Methods of using cyanovirins to inhibit viral infection

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 1, 2004 · Expires May 27, 2024

US 6737251

Nucleotide and deduced amino acid sequences of tumor gene Int6

The United States of America, as represented by the Department of Health and Human Services · Granted May 18, 2004 · Expires May 13, 2024

US 6737511

Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis

The United States of America, as represented by the Department of Health and Human Services · Granted May 18, 2004 · Expires May 13, 2024

US 6734014

Methods and compositions for transforming dendritic cells and activating T cells

The United States of America, as represented by the Department of Health and Human Services · Granted May 11, 2004 · Expires May 6, 2024

US 6730498

Production of functional proteins: balance of shear stress and gravity

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted May 4, 2004 · Expires Apr 29, 2024

US 6719978

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services · Granted Apr 13, 2004 · Expires Apr 8, 2024

US 6716450

Enhancing protein activity through nanoencapsulation

The United States of America as represented by the Secretary of the Army · Granted Apr 6, 2004 · Expires Apr 1, 2024

US 6713446

Formulation of boronic acid compounds

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6713444

Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus neurotoxins

The United States of America as represented by the Secretary of the Army · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6713284

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6713081

Ocular therapeutic agent delivery devices and methods for making and using such devices

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6713066

Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6709842

DNA encoding a growth factor specific for epithelial cells

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 23, 2004 · Expires Mar 18, 2024

US 6710166

41 kDa Cryptosporidium parvum oocyst wall protein

The United States of America, as represented by the Secretary of Agriculture · Granted Mar 23, 2004 · Expires Mar 18, 2024

US 6706754

Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

The United States of America as represented by the Secretary of the Army · Granted Mar 16, 2004 · Expires Mar 11, 2024

US 6706873

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 16, 2004 · Expires Mar 11, 2024

US 6703046

Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use

The United States of America · Granted Mar 9, 2004 · Expires Mar 4, 2024

US 6699835

Formulation of boronic acid compounds

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 2, 2004 · Expires Feb 26, 2024

US 6699842

Dominant negative deletion mutants of C-jun and their use in the prevention and treatment of cancer

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 2, 2004 · Expires Feb 26, 2024

US 6696242

Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 24, 2004 · Expires Feb 19, 2024